Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

2,247 total articles

Newmont Is Printing Cash — A Tactical Long While Gold Momentum Recovers

Newmont Is Printing Cash — A Tactical Long While Gold Momentum Recovers

Newmont has turned rock into cash: $7.3B of free cash flow, a sub-0.2 debt/equity ratio and double-digit returns on capital give the company both optionality and room to return capital. With gold still above pre-surge levels and miners trading on reasonable multiples (P/E ~19, EV/EBITDA ~9.9), we like a tactical long in NEM for a mid-term swing whi…

M/I Homes: A Defensive Growth Long in a Tough Housing Patch

M/I Homes: A Defensive Growth Long in a Tough Housing Patch

M/I Homes (MHO) combines a low-teens ROE, positive free cash flow and conservative leverage with a sub-10x P/E multiple and diversified regional footprint. In a housing market under pressure from higher rates, MHO's balance sheet, mortgage services unit and valuation profile create an asymmetric risk/reward for a mid-term long trade. Entry $141.11,…

Vanda After the Bysanti Pop: A Measured Long with a Clear Exit

Vanda After the Bysanti Pop: A Measured Long with a Clear Exit

Vanda Pharmaceuticals (VNDA) has ripped higher on the Bysanti approval news, trading at $8.39 with heavy volume and a refreshed commercial story. The company’s market cap sits near $495M and revenue trends show modest growth, but negative free cash flow and a history of losses mean this is a high-risk, reward-managed long. This trade idea lays out …

Nike Setup: Buy the Dip for a 180-Day Rebound

Nike Setup: Buy the Dip for a 180-Day Rebound

Nike is trading below key moving averages after a pullback that priced in tariff headwinds and softer China demand. With a $92.5B market cap, $2.48B of free cash flow and a 2.46% dividend yield, the balance sheet and brand give Nike room to recover. Catalysts over the next 3-6 months - including a Supreme Court ruling easing tariff risk (02/23/2026…

InnovAge - A Risk-Reward Trade: Regulatory Overhang Is Priced In, But Operational Momentum Could Surprise

InnovAge - A Risk-Reward Trade: Regulatory Overhang Is Priced In, But Operational Momentum Could Surprise

InnovAge (INNV) has been through litigation and volatility; recent moves suggest much of the bad news is already priced into the stock. Revenue growth and improving margins give a plausible path to upside, but high valuation multiples and regulatory sensitivity make this a medium-risk trade. Enter on weakness, size carefully, and use a defined stop…

Wegovy’s Momentum Is Underpriced: A Mid-Term Long on Novo Nordisk

Wegovy’s Momentum Is Underpriced: A Mid-Term Long on Novo Nordisk

Novo Nordisk (NVO) has been hammered on trial headlines and short-term fears, but underlying demand for weight-loss therapies and expanding oral formulations support a mid-term trade. At $47.42 the stock reflects pessimism about 2026 sales that may already be priced in. This trade targets a rebound as Wegovy adoption steadies and market growth expe…

Continental - Why Adjusted Post-Spin Performance Deserves a Second Look

Continental - Why Adjusted Post-Spin Performance Deserves a Second Look

The headline chart for Continental (CTTAY) understates the company's operational momentum after a corporate separation. Adjusted for the spin-off, technicals are bullish, industry secular growth in ADAS and vehicle electrification supports higher earnings, and OTC positioning provides a favorable risk/reward for a mid-term swing trade. Entry $8.70,…

Backing Sephience: A Long Trade on PTC Therapeutics Into 2026

Backing Sephience: A Long Trade on PTC Therapeutics Into 2026

PTC Therapeutics is transitioning from royalty receipts to product-led growth centered on Sephience (PKU). With a market cap near $5.7B, strong free cash flow generation and an undemanding EV/EBITDA multiple, PTCT offers a structured long opportunity: entry $70.60, target $95.00, stop $58.00, trade horizon 180 trading days.

Visa: Buy a Global Payments Franchise at an Attractive Total-Return Entry

Visa: Buy a Global Payments Franchise at an Attractive Total-Return Entry

Visa remains one of the highest-quality, capital-light global payment networks. With $22.9B in free cash flow, ROE near 44%, and a market cap around $612B, the company combines defensive economics with durable growth. Recent multiple compression creates a buying opportunity for investors targeting total return over the next 6-9 months, provided reg…

Reddit Rally: A Tactical Upgrade Into a Mispriced Growth Story

Reddit Rally: A Tactical Upgrade Into a Mispriced Growth Story

Reddit (RDDT) just served a clear reminder that its growth engine is intact: 70% revenue growth in the last quarter, robust free cash flow and a partnership that monetizes its vast audience. The shares have been punished on user-growth concerns and multiple compression, creating a reward-to-risk setup for a long trade. My plan: enter at $150.14, st…